Skip to main content
Premium Trial:

Request an Annual Quote

BioNano Genomics Raises $5M

NEW YORK (GenomeWeb) – Genome mapping company BioNano Genomics said in a regulatory filing that it raised $5 million toward a targeted $6.1 million financing round.

In a document filed with the US Securities and Exchange Commission last week, BioNano said that the type of securities offered included debt; option, warrant, or other rights to acquire another security; and security to be acquired upon the exercise of an option, warrant, or other right to acquire security.

The firm did not disclose the investors in the round or say how proceeds would be used. Through a spokesperson, the company declined to comment.

In October, the San Diego firm raised $10 million to support the development and commercialization of its human genome analysis platform called Irys, which images extremely long molecules for the observation of native genomic structure.